Thu.Jan 11, 2024

article thumbnail

AI-discovered ALS drug trial uses unique remote monitoring

Drug Discovery World

Verge Genomics has initiated a Phase Ib proof-of-concept study for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS) with VRG50635. VRG50635 is a small molecule PIKfyve inhibitor and is reportedly one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled platform.

article thumbnail

The Political Theater Of Importing Prescription Drugs From Canada

Forbes: Drug Truths

The FDA had been previously reluctant to approve such a plan for safety concerns.

FDA 249
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New podcast: Revolutionary technology for drug discovery and development

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine ; Predictive diagnostics: closing the precision medicine gap ; and FAIR Game: making data work harder in the race to market.

Vaccine 148
article thumbnail

Scientists identify how dietary restriction slows brain aging and increases lifespan

Science Daily: Pharmacology News

Restricting calories is known to improve health and increase lifespan, but much of how it does so remains a mystery, especially in regard to how it protects the brain. Scientists have now uncovered a role for a gene called OXR1 that is necessary for the lifespan extension seen with dietary restriction and is essential for healthy brain aging.

140
140
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Research reveals therapeutic potential of mRNA in rare diseases

Drug Discovery World

Researchers have used messenger RNA (mRNA) to create an effective therapy for a rare liver disease in preclinical studies, demonstrating the technology’s potential therapeutic use in people. The team, led by University College London (UCL), King’s College London and Moderna scientists, found that mRNA could be used to correct a rare genetic liver disease known as argininosuccinic aciduria in a mouse model.

Disease 148
article thumbnail

Addgene is Stopping Use of X (formerly Twitter)

addgene Blog

Addgene is announcing we have chosen to stop all activity on X, formerly Twitter. If you are interested in engaging with us on social media, you can find us on Bluesky: @addgene.bsky.social; or @addgene on Instagram, TikTok, Facebook, and LinkedIn. We are also exploring other social media platforms with active scientific communities and welcome suggestions in the comments.

127
127

More Trending

article thumbnail

Overuse of Antifungal Skin Meds Could Be Driving Drug-Resistant Disease

Drugs.com

THURSDAY, Jan. 11, 2024 -- U.S. doctors are prescribing antifungal creams to patients with skin complaints at rates so high they could be contributing to the rise of drug-resistant infections, new research shows.These are "severe.

Doctors 116
article thumbnail

SandboxAQ acquisition to accelerate AI simulation for drug discovery

Drug Discovery World

SandboxAQ has acquired Good Chemistry, a computational chemistry company that leverages AI, quantum and other advanced technologies to accelerate drug discovery. Good Chemistry, which spun out of 1Qbit in 2021, is SandboxAQ’s second acquisition and its first in the AI simulation sector. “Good Chemistry’s software and existing partnerships will enable us to rapidly accelerate how we bring the benefits of advanced simulation and AI tools to more customers,” said Dr Nadia Ca

article thumbnail

Catalytic combo converts CO2 to solid carbon nanofibers

Science Daily: Pharmacology News

Scientists have developed a way to convert carbon dioxide (CO2), a potent greenhouse gas, into carbon nanofibers, materials with a wide range of unique properties and many potential long-term uses. Their strategy uses tandem electrochemical and thermochemical reactions run at relatively low temperatures and ambient pressure and could successfully lock carbon away to offset or even achieve negative carbon emissions.

114
114
article thumbnail

FDA to Import Syphilis Drug, Extencilline, From France Amid Shortage

Drugs.com

THURSDAY, Jan. 11, 2024 -- Amid an ongoing shortage of the first-line treatment for syphilis in the United States, the U.S. Food and Drug Administration will allow the importation of a different syphilis drug from a French drugmaker. In a.

FDA 111
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Record heat in 2023 worsened global droughts, floods and wildfires

Science Daily: Pharmacology News

Record heat across the world profoundly impacted the global water cycle in 2023, contributing to severe storms, floods, megadroughts and bushfires, new research shows.

Research 108
article thumbnail

FDA to Import Syphilis Drug From France Amid Shortage

Drugs.com

THURSDAY, Jan. 11, 2024 -- Amid an ongoing shortage of the first-line treatment for syphilis in the United States, the U.S. Food and Drug Administration will allow the importation of a different syphilis drug from a French drugmaker.In a.

FDA 98
article thumbnail

Transparent brain implant can read deep neural activity from the surface

Science Daily: Pharmacology News

Researchers have developed a neural implant that provides information about activity deep inside the brain while sitting on its surface. The implant is made up of a thin, transparent and flexible polymer strip that is packed with a dense array of graphene electrodes. The technology, tested in transgenic mice, brings the researchers a step closer to building a minimally invasive brain-computer interface (BCI) that provides high-resolution data about deep neural activity by using recordings from t

article thumbnail

Stroke Hits Black Americans at Younger Ages Than Whites

Drugs.com

THURSDAY, Jan. 11, 2024 -- Black Americans have strokes nearly a decade younger on average than white people, a new study has found.The study also revealed that Black people consistently had a higher rate of stroke than white folks over a 22-year.

98
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

City of Hope research reveals an immune cell that can attack cancer

SCIENMAG: Medicine & Health

Credit: City of Hope Journal Cell Method of Research Experimental study Subject of Research Cells Article Title Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death Article Publication Date 10-Jan-2024

article thumbnail

'Ancient Gene Bank' Gives Clues to Diseases Common to Europeans

Drugs.com

THURSDAY, Jan. 11, 2024 -- DNA locked in the bones and teeth of more than 5,000 humans who lived in Asia and Europe up to 34,000 years ago are providing vital clues to a myriad of present-day medical conditions.The descendants of these ancient.

DNA 98
article thumbnail

Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy

SCIENMAG: Medicine & Health

Reston, VA (January 11, 2024)—A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine.

article thumbnail

All Pain Is Not the Same When It Comes to MS

Drugs.com

THURSDAY, Jan. 11, 2024 -- Pain can present itself in many forms for people battling multiple sclerosis, and one type can interfere with exercising, new research shows.One class of pain experienced by MS patients is what the authors of the new.

article thumbnail

Newly optimistic, biotech investors weigh lessons of sector’s downturn

BioPharma Drive: Drug Pricing

Investors and executives interviewed by BioPharma Dive at J.P. Morgan say new companies have to be leaner, hire more conservatively and focus on their first medicines quickly.

88
article thumbnail

Biorobotic Heart Imitates the Real Thing and Could Further Research

Drugs.com

THURSDAY, Jan. 11, 2024 -- A biorobotic heart that combines a biological pig heart with a silicone robotic pump is providing researchers with a new tool to understand and potentially treat heart disease.Scientists built the heart by replacing the.

article thumbnail

Researchers discover potential microbiome links to skin aging

SCIENMAG: Medicine & Health

The effects of aging and external factors like UV exposure on skin are well documented. As people age or spend more time in the sun, their skin tends to become drier and more wrinkled, Credit: University of California San Diego The effects of aging and external factors like UV exposure on skin are well documented.

article thumbnail

Oldest known fossilized skin is 21 million years older than previous examples

Science Daily: Pharmacology News

Researchers have identified a 3D fragment of fossilized skin that is at least 21 million years than previously described skin fossils. The skin, which belonged to an early species of Paleozoic reptile, has a pebbled surface and most closely resembles crocodile skin. It's the oldest example of preserved epidermis, the outermost layer of skin in terrestrial reptiles, birds, and mammals, which was an important evolutionary adaptation in the transition to life on land.

article thumbnail

Understanding healthy and happy expectancy in former soviet countries

SCIENMAG: Medicine & Health

The dissolution of the Soviet Union in 1991 marked the start of a period ripe with political, economic, and societal changes. In many former Soviet countries, these abrupt and turbulent transformations posed massive challenges to healthcare systems.

81
article thumbnail

Researchers discover potential microbiome links to skin aging

Science Daily: Pharmacology News

Recent findings have identified a potential new link to signs of skin aging -- the skin microbiome, the collection of microorganisms that inhabits our skin.

article thumbnail

Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors

Covalent Modifiers

Aaron B. Keeley, Aleksandra Kopranovic, Vincenzo Di Lorenzo, Péter Ábrányi-Balogh, Niklas Jänsch, Linh N. Lai, László Petri, Zoltán Orgován, Daniel Pölöske, Anna Orlova, András György Németh, Charlotte Desczyk, Tímea Imre, Dávid Bajusz, Richard Moriggl, Franz-Josef Meyer-Almes, and György M. Keserü Journal of Medicinal Chemistry 2024 67 (1), 572-585 [link] Screening of ultra-low-molecular weight ligands (MiniFrags) successfully identified viable chemical starting points for a variety of drug tar

Drugs 73
article thumbnail

Astronomers make rare exoplanet discovery, and a giant leap in detecting Earth-like bodies

Science Daily: Pharmacology News

Astronomers have made the rare discovery of a small, cold exoplanet and its massive outer companion -- shedding light on the formation of planets like Earth.

79
article thumbnail

SureChEMBL user survey

The ChEMBL-og

(Generated with DALL-E 3 ∙ 11 Janvier 2024 at 11:50 am) Happy New Year everyone! You already know that we have been working extensively in the last few years to offer a new version of SureChEMBL that can deliver a better user experience. If you did not have the opportunity yet, you can still test the new UI and underlying system. Obviously it is still a beta version but new improvements are deployed weekly and 2024 should be exciting.

62
article thumbnail

Our surprising magnetic galaxy

Science Daily: Pharmacology News

A team of astronomers has created the first-ever map of magnetic field structures within a spiral arm of our Milky Way galaxy. Previous studies on galactic magnetic fields only gave a very general picture, but the new study reveals that magnetic fields in the spiral arms of our galaxy break away from this general picture significantly and are tilted away from the galactic average by a high degree.

71
article thumbnail

High-Affinity Fluorogenic Substrate for Tissue Transglutaminase Reveals Enzymatic Hysteresis [@theKeillors]

Covalent Modifiers

Eric W. J. Gates, Adrien Prince-Hallée, Yasaman Heidari, Abootaleb Sedighi, and Jeffrey W. Keillor Biochemistry 2023 62 (21), 3085-3095 DOI: 10.1021/acs.biochem.3c00337 Transglutaminases (TGases) are a family of calcium-dependent enzymes primarily known for their ability to cross-link proteins. Transglutaminase 2 (TG2) is one isozyme in this family whose role is multifaceted.

article thumbnail

Need for speed: How hummingbirds switch mental gears in flight

Science Daily: Pharmacology News

Hummingbirds use two distinct sensory strategies to control their flight, depending on whether they're hovering or in forward motion, according to new research.

article thumbnail

Venture funding, dealmaking slowed in biotech last year: Pitchbook

BioPharma Drive: Drug Pricing

Though the number of financings from private investors is down year over year, the size of those rounds has remained high, especially for drugmakers with human data in hand.

62
article thumbnail

New study pinpoints the weaknesses in AI

Science Daily: Pharmacology News

ChatGPT and other solutions built on Machine Learning are surging. But even the most successful algorithms have limitations. Researchers have now proven mathematically that apart from simple problems it is not possible to create algorithms for AI that will always be stable. The study may lead to guidelines on how to better test algorithms and reminds us that machines do not have human intelligence after all.

article thumbnail

New patent for Merck Sharp drug WELIREG

Drug Patent Watch

Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two… The post New patent for Merck Sharp drug WELIREG appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

“Thaw Out” with Pharma Thought Leaders at the 2024 Puerto Rico Pharmaceutical Summit: HPM Directors to Discuss Drug Approvals and Puerto Rico “Exportation” Best Practices

FDA Law Blog: Biosimilars

Two Hyman, Phelps & McNamara, P.C. (HPM) Directors, Karla Palmer and Dara Levy , will present at the Puerto Rico Pharmaceutical Summit 2024, February 6, 2024, at the La Concha Renaissance San Juan Resort in San Juan, Puerto Rico. This day-long (FREE) seminar is a must-attend event for anyone in the pharmaceutical sector interested in understanding the “ins and outs” of doing business in the Territory, as well as an opportunity to interact with those who already have a keen understanding of